BBIXF:OTC-Bonus BioGroup Ltd (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 0.03

Change

0.00 (0.00)%

Market Cap

USD 0.06B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-11 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
UCBJY UCB SA ADR

+0.12 (+0.14%)

USD 32.67B
ARGNF argenx SE

+33.12 (+7.09%)

USD 30.19B
UCBJF UCB SA

N/A

USD 29.76B
GNMSF Genmab A/S

+4.11 (+1.47%)

USD 17.95B
ZLDPF Zealand Pharma A/S

N/A

USD 9.41B
IVBIY IVBIY

N/A

USD 8.08B
SBMFF Sino Biopharmaceutical Limited

N/A

USD 6.60B
SBHMY Sino Biopharmaceutical Ltd ADR

N/A

USD 6.60B
WXXWY WuXi Biologics (Cayman) Inc

+0.02 (+0.82%)

USD 5.76B
WXIBF WuXi Biologics

N/A

USD 5.74B

ETFs Containing BBIXF

IXN iShares Global Tech ETF 1,000.00 % 0.46 %

-2.18 (-2.10%)

N/A
SOXX iShares Semiconductor ETF 1,000.00 % 0.46 %

-11.61 (-2.10%)

USD 13.89B
QCLN First Trust NASDAQ® Clea.. 8.55 % 0.60 %

-1.88 (-2.10%)

USD 0.70B
VNSE Natixis ETF Trust II - Na.. 4.20 % 0.00 %

-0.68 (-2.10%)

USD 0.03B
XSD SPDR® S&P Semiconductor .. 3.48 % 0.35 %

-13.54 (-2.10%)

N/A
QTEC First Trust NASDAQ-100-Te.. 2.93 % 0.57 %

-8.01 (-2.10%)

USD 3.83B
MIDF 1.54 % 0.00 %

N/A

N/A
QQEW First Trust NASDAQ-100 Eq.. 1.16 % 0.60 %

-3.13 (-2.10%)

USD 1.99B

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 50.00% 79% B- 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 50.00% 79% B- 86% B+
Trailing 12 Months  
Capital Gain -25.00% 63% D 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -25.00% 63% D 37% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 589.33% 90% A- 94% A
Dividend Return 589.33% 90% A- 94% A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 2,827.30% 10% F 6% D-
Risk Adjusted Return 20.84% 74% C 55% F
Market Capitalization 0.06B 69% C- 52% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector